File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1365-2125.2011.04097.x
- Scopus: eid_2-s2.0-84857018427
- PMID: 22023024
- WOS: WOS:000300446400003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The pharmacogenetics of the response to warfarin in Chinese
Title | The pharmacogenetics of the response to warfarin in Chinese |
---|---|
Authors | |
Keywords | Algorithm Chinese CYP2C9 gene VKORC1 gene Warfarin |
Issue Date | 2012 |
Publisher | Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/BJCP |
Citation | British Journal Of Clinical Pharmacology, 2012, v. 73 n. 3, p. 340-347 How to Cite? |
Abstract | Warfarin is a commonly used oral anticoagulant with a narrow therapeutic range and large interindividual variability in daily dose. Compared with Caucasians, Chinese are known to require lower doses of warfarin. Differences between Caucasians and Chinese in the allelic frequencies of two genes, CYP2C9 and VKORC1, largely explain the difference in dose requirement. There are other genetic polymorphisms that may further explain the response to warfarin. The VKORC1 genotype is an important determinant of response to warfarin in Chinese, but some genetic variants found in other ethnic groups that have a large effect on warfarin response and dosing are not commonly found in Chinese. Therefore, it is important to recognize and beware of ethnic differences in the pharmacogenetics of the response to warfarin, especially in the design of algorithms to aid dosing in clinical practice. © 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society. |
Persistent Identifier | http://hdl.handle.net/10722/152743 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 1.046 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lam, MPS | en_HK |
dc.contributor.author | Cheung, BMY | en_HK |
dc.date.accessioned | 2012-07-16T09:47:29Z | - |
dc.date.available | 2012-07-16T09:47:29Z | - |
dc.date.issued | 2012 | en_HK |
dc.identifier.citation | British Journal Of Clinical Pharmacology, 2012, v. 73 n. 3, p. 340-347 | en_HK |
dc.identifier.issn | 0306-5251 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/152743 | - |
dc.description.abstract | Warfarin is a commonly used oral anticoagulant with a narrow therapeutic range and large interindividual variability in daily dose. Compared with Caucasians, Chinese are known to require lower doses of warfarin. Differences between Caucasians and Chinese in the allelic frequencies of two genes, CYP2C9 and VKORC1, largely explain the difference in dose requirement. There are other genetic polymorphisms that may further explain the response to warfarin. The VKORC1 genotype is an important determinant of response to warfarin in Chinese, but some genetic variants found in other ethnic groups that have a large effect on warfarin response and dosing are not commonly found in Chinese. Therefore, it is important to recognize and beware of ethnic differences in the pharmacogenetics of the response to warfarin, especially in the design of algorithms to aid dosing in clinical practice. © 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society. | en_HK |
dc.language | eng | en_US |
dc.publisher | Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/BJCP | en_HK |
dc.relation.ispartof | British Journal of Clinical Pharmacology | en_HK |
dc.subject | Algorithm | - |
dc.subject | Chinese | - |
dc.subject | CYP2C9 gene | - |
dc.subject | VKORC1 gene | - |
dc.subject | Warfarin | - |
dc.subject.mesh | Algorithms | en_HK |
dc.subject.mesh | Anticoagulants - administration & dosage | en_HK |
dc.subject.mesh | Aryl Hydrocarbon Hydroxylases - genetics | en_HK |
dc.subject.mesh | Asian Continental Ancestry Group - genetics | en_HK |
dc.subject.mesh | Dose-Response Relationship, Drug | en_HK |
dc.subject.mesh | European Continental Ancestry Group - genetics | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Mixed Function Oxygenases - genetics | en_HK |
dc.subject.mesh | Pharmacogenetics | en_HK |
dc.subject.mesh | Polymorphism, Genetic | en_HK |
dc.subject.mesh | Warfarin - administration & dosage | en_HK |
dc.title | The pharmacogenetics of the response to warfarin in Chinese | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Cheung, BMY:mycheung@hku.hk | en_HK |
dc.identifier.authority | Cheung, BMY=rp01321 | en_HK |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1111/j.1365-2125.2011.04097.x | en_HK |
dc.identifier.pmid | 22023024 | - |
dc.identifier.scopus | eid_2-s2.0-84857018427 | en_HK |
dc.identifier.hkuros | 201113 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-84857018427&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 73 | en_HK |
dc.identifier.issue | 3 | en_HK |
dc.identifier.spage | 340 | en_HK |
dc.identifier.epage | 347 | en_HK |
dc.identifier.isi | WOS:000300446400003 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Lam, MPS=54989440600 | en_HK |
dc.identifier.scopusauthorid | Cheung, BMY=7103294806 | en_HK |
dc.customcontrol.immutable | csl 130312 | - |
dc.identifier.issnl | 0306-5251 | - |